PREVENTIV MEASURES - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
77860437
Word Mark
PREVENTIV MEASURES
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2010-09-29
Filing Date
2009-10-29
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
L90
Employee Name
RAUEN, JAMES A
Statements
Goods and Services
Labels sold as an integral component of pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, anti-infectives, anti-inflammatory agents, anticonvulsants, antiemetics, anxiolytics, blood modifiers, cardiovasculars, diuretics, hormones, diluents, oncolytics, transplantation agents, imaging agents, vascular targeting agents, cancer treatments, and vascular disease treatments; Labels sold as an integral component of pre-filled syringes sold filled with alkalizing agents, labels sold as an integral component of pre-filled syringes sold filled with analgesics and anesthetics, labels sold as an integral component of pre-filled syringes sold filled with antacids, labels sold as an integral component of pre-filled syringes sold filled with anticholinergics, labels sold as an integral component of pre-filled syringes sold filled with anti-infectives, labels sold as an integral component of pre-filled syringes sold filled with anti-inflammatory agents, labels sold as an integral component of pre-filled syringes sold filled with anticonvulsants, labels sold as an integral component of pre-filled syringes sold filled with antiemetics, labels sold as an integral component of pre-filled syringes sold filled with anxiolytics, labels sold as an integral component of pre-filled syringes sold filled with blood modifiers, labels sold as an integral component of pre-filled syringes sold filled with cardiovasculars, labels sold as an integral component of pre-filled syringes sold filled with diuretics, labels sold as an integral component of pre-filled syringes sold filled with hormones, labels sold as an integral component of pre-filled syringes sold filled with diluents, labels sold as an integral component of pre-filled syringes sold filled with oncolytics, labels sold as an integral component of pre-filled syringes sold filled with transplantation agents, labels sold as an integral component of pre-filled syringes sold filled with imaging agents, labels sold as an integral component of pre-filled syringes sold filled with vascular targeting agents, labels sold as an integral component of pre-filled syringes sold filled with cancer treatments, and labels sold as an integral component of pre-filled syringes sold filled with vascular disease treatments; Labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of pain; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of infections; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of cardiovascular disease; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of hormonal imbalances; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of heartburn; labels sold as an integral component of injectable drugs and therapeutic solutions for imaging; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of pain sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of cardiovascular disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of hormonal imbalances sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of heartburn sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for imaging sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors
Pseudo Mark
PREVENTIVE MEASURES
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2009-11-04
Primary Code
005
Correspondences
Name
MARCIA IRELAND ROSENFELD
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2009-11-02 | NEW APPLICATION ENTERED IN TRAM |
2009-11-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2009-11-05 | NOTICE OF PSEUDO MARK MAILED |
2010-02-03 | ASSIGNED TO EXAMINER |
2010-02-04 | NON-FINAL ACTION WRITTEN |
2010-02-04 | NON-FINAL ACTION E-MAILED |
2010-02-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2010-09-29 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2010-09-29 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |